- Home
- PLMR vs CLDX Comparison
PLMR vs CLDX Comparison
Compare PLMR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLMR | CLDX |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PLMR | CLDX |
|---|---|---|
| Price | $144.71 | $40.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $153.60 | $46.60 |
| AVG Volume (30 Days) | 297.0K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.04 | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $875,967,000.00 | $12,743,000.00 |
| Revenue This Year | $192.25 | $111.39 |
| Revenue Next Year | $19.34 | $235.85 |
| P/E Ratio | $92.54 | ★ N/A |
| Revenue Growth | 58.16 | ★ 87.78 |
| 52 Week Low | $100.81 | $19.72 |
| 52 Week High | $147.44 | $40.30 |
Technical Indicators
Market Signals| Indicator | PLMR | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 81.66 | 76.89 |
| Support Level | $111.33 | $28.51 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 5.14 | 1.71 |
| MACD | 3.24 | 0.70 |
| Stochastic Oscillator | 91.77 | 98.99 |
Price Performance
Historical ComparisonAbout PLMR Palomar Holdings Inc.
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.